BioNexus Gene Lab (BGLC) Capital Leases (2018 - 2026)
BioNexus Gene Lab (BGLC) reported Capital Leases of $46605.0 for Q1 2026, up 257.92% sequentially from $13021.0 in Q1 2022.
BioNexus Gene Lab (BGLC) Capital Leases (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 6 years of Capital Leases data on file, last reported at $46605.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Leases changed N/A year-over-year to $46605.0; the trailing twelve-month figure through Mar 2026 stood at $46605.0 (changed N/A YoY), and the FY2021 full-year result was $12803.0, down 63.72% from the prior year.
- Capital Leases grew to $46605.0 in Q1 2026, from $13021.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $46605.0 in Q1 2026 to a low of $13021.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,605.00 |
| Mar 31, 2022 | 13,021.00 |
| Dec 31, 2021 | 12,803.00 |
| Sep 30, 2021 | 18,103.00 |
| Jun 30, 2021 | 23,610.00 |
| Mar 31, 2021 | 28,948.00 |
| Dec 31, 2020 | 35,292.00 |
| Sep 30, 2020 | 39,500.00 |
| Jun 30, 2020 | 38,366.00 |
| Mar 31, 2020 | 38,169.00 |
| Dec 31, 2019 | 45,086.00 |
| Sep 30, 2019 | 49,094.00 |
| Mar 31, 2019 | 58,825.00 |
| Dec 31, 2018 | 62,935.00 |